Quarterly report pursuant to Section 13 or 15(d)

Assets Purchase Agreements (Details)

v3.24.2.u1
Assets Purchase Agreements (Details)
$ in Thousands
 6 Months Ended
Jun. 27, 2024
USD ($)
May 13, 2024
item
Jul. 28, 2023
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Asset Acquisition [Line Items]          
Property, plant and equipment, held for sale       $ 2,209 $ 0
June 2024 Repurchase of Assets          
Asset Acquisition [Line Items]          
Purchase price $ 1,400     $ 1,400  
Upfront payment $ 100        
Upfront payment, due period from Effective Date 5 days        
Subsequent payment $ 1,300        
Subsequent amount, due period from closing date 12 months        
Amount of net assets below this threshold, the Company may elect to delay payment obligation by additional six months $ 20,000        
Extension term for deferred payment 6 months        
Interest rate on outstanding Deferred Amount 5.00%        
Rate of interest accrual on Deferred Amount not paid in full after 12 months 12 months        
Amount of net receivables to forgive under Asset Purchase Agreement $ 3,300        
Outstanding receivables 6,900        
Outstanding payables 3,600        
Total purchase consideration 4,700        
Fair value provided from valuation services less costs to sell 2,200        
Purchase consideration allocated to the supplies repurchased 2,500        
Supplies repurchased with no alternate future use recognized as research and development expense 2,200        
Supplies repurchased with alternate future use recognized as research and development expense 300        
Property, plant and equipment, held for sale $ 2,200        
uBriGene          
Asset Acquisition [Line Items]          
Proceeds from the sale of property and equipment     $ 6,000    
Gain on sale of property and equipment     1,400    
Sale consideration considered deferred income     $ 300    
Number of parties obligated to terminate agreements | item   2      
Equipment assets purchased term   180 days